T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
Schoelinck J, Gervasoni J, Guillermin Y, Beillard E, Pissaloux D, Chassagne-Clement C.
Virchows Arch. 2024 May;484(5):853-857. doi: 10.1007/s00428-023-03693-5. Epub 2023 Nov 20.
Clinicopathological differences between T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblastic leukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: An analysis of 41 adult cases.
Takahashi Y, Kaimi Y, Taniguchi H, Ochi T, Makino H, Makita S, Iwaki N, Fukuhara S, Munakata W, Izutsu K, Maeshima AM.
Hum Pathol. 2024 Aug;150:78-85. doi: 10.1016/j.humpath.2024.06.016. Epub 2024 Jun 28.
Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS).
Klocke H, Dong ZM, O'Brien C, Burwick N, Richard RE, Wu DY, Chauncey TR, Graf SA.
Case Rep Hematol. 2020 Oct 10;2020:8811673. doi: 10.1155/2020/8811673. eCollection 2020.
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia.
Tota G, Coccaro N, Zagaria A, Anelli L, Casieri P, Cellamare A, Minervini A, Minervini CF, Brunetti C, Impera L, Carluccio P, Cumbo C, Specchia G, Albano F.
BMC Cancer. 2014 Dec 16;14:963. doi: 10.1186/1471-2407-14-963.
Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report.
Wang P, Peng X, Deng X, Gao L, Zhang X, Feng Y.
Medicine (Baltimore). 2018 Oct;97(41):e12743. doi: 10.1097/MD.0000000000012743.
[Successful treatment with clarithromycin for Mixed phenotype acute leukemia, T/myeloid, NOS].
Ohe M, Hashino S.
Rinsho Ketsueki. 2010 Apr;51(4):297-9.
